GrantQuick

health · HHS-NIH11

Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

National Institutes of Health · RFA-AI-27-005

29 days left

Total Program Funding

$18.0M

Expected Awards

1

Deadline

November 10, 2026

GRANTQUICK SUMMARYPlain-English Overview

Clinical Research Network on Antimicrobial Resistance. National Institutes of Health. The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by continuing support for a Clinical Research Network on Antimicrobial Resistance (AMR). AMR is a major health challenge that limits treatment options and allows resistant infections to persist.... $15,000,000 total program funding; ~1 awards expected.

Who Should Apply

Other eligible entities, Other Native American Tribal Organizations, For-profit organizations, Nonprofits (non-501c3), Special district governments (+5 more)

Who Should NOT Apply

Organizations not matching the eligible applicant types listed above

Key Requirements (Plain English)

  • •Other Eligible ApplicantsFaith-based or Community-based Organizations;Regional Organizations

💡 GrantQuick Tip

High-value award — invest significantly in proposal quality. Consider hiring a grant writer.

Competitiveness: Very high — extremely limited awards available

What This Grant Funds

The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrated CRN. The CRN will comprise four centers: the Scientific Leadership Center (SLC), the Clinical Operations Center (COC), the Laboratory Center (LC), and the Statistics and Data Coordination Center (SDCC).

Attachments

Who Can Apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. NIH will no longer issue awards (i.e., new, renewal, or non-competing continuation) to domestic or foreign entities that involve foreign subawards/subcontracts. All NIH-funded research involving foreign subawards/subcontracts must be submitted in response to a NOFO that is specifically designated for funded international collaborations. See NIH Grants Policy Statement 16.8 Collaborative International Research Awards.Applications involving foreign subawards/subcontracts submitted in response to this NOFO will be deemed noncompliant and will not be considered for funding. This policy applies to all monetary international collaborations resulting in foreign subawards/subcontracts, however, it does not preclude unfunded international collaborations or foreign components, funding for foreign consultants, or procurement of unique equipment or supplies from foreign vendors.

Eligible Applicant Types

Federally Recognized Tribal GovernmentsCity/Township GovernmentsSpecial District GovernmentsIndependent School DistrictsPublic Colleges & UniversitiesPrivate Colleges & UniversitiesOther (see NOFO for details)Nonprofits without 501(c)(3)State GovernmentsOther Tribal OrganizationsCounty GovernmentsPublic And Indian Housing AuthoritiesFor-Profit Organizations501(c)(3) NonprofitsSmall Businesses

Funding Details

Total Program Funding
$18.0M
Expected Number of Awards
1
Cost Sharing Required?
No
Funding Instrument
cooperative_agreement

Key Dates

Posted: September 1, 2026
Application Deadline: November 10, 2026 (29 days remaining)

Agency Contact

Division of Microbiology and Infectious Diseases AMRClinicalResearchNetworkContact@mail.nih.gov

AMRClinicalResearchNetworkContact@mail.nih.gov

Ready to apply?

View the full NOFO and submit your application on Grants.gov